On January 24, 2022, Bio Protech Inc. closed the transaction. The company has issued 386,664 convertible redeemable preferred shares at the price of KRW 750 per share for gross proceeds of KRW 289,998,000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
747 KRW | 0.00% | -6.27% | -17.91% |
1st Jan change | Capi. | |
---|---|---|
-17.91% | 7.91M | |
-21.31% | 17.75B | |
-42.93% | 2.85B | |
+18.67% | 1.92B | |
-7.25% | 1.58B | |
-18.78% | 952M | |
-24.92% | 888M | |
+4.64% | 828M | |
-28.00% | 611M | |
+19.10% | 591M |
- Stock Market
- Equities
- A199290 Stock
- News Bio Protech Inc.
- Bio Protech Inc. announced that it has received KRW 289.998 million in funding from Mijin Company Co., Ltd.